(Photo: Rept0n1x via Wikimedia Commons)

Bristol Myers Squibb is the third entity this month to file a lawsuit against the U.S. government, challenging the Inflation Reduction Act’s Medicare drug price negotiation program. The lawsuit calls for a halt to the program, alleging it violates the First and Fifth Amendments of the U.S. Constitution.

“The IRA [Inflation Reduction Act] does this by requiring BMS and other pharmaceutical companies to provide innovative medicines to third parties at prices set by the government, without any requirement that those prices reflect fair market value,” Bristol Myers Squibb said in a statement. “The IRA makes manufacturers of innovative medicines state publicly that the government’s price setting is a true negotiation that resulted in a fair price, even if it was not. The First Amendment protects citizens from just this sort of forced speech.”

Eliquis, a blood thinner that is one of the top-selling drugs produced by Bristol Myers, is expected by analysts to be among the first 10 drugs subject to the price negotiations. Those are slated to begin in September and focus on the prescription drugs on which the U.S. government spends the most. CNBC.com reports that Eliquis generated nearly $12 billion in revenue for Bristol Myers Squibb in 2022 — about one-quarter of the company’s $46 billion in total revenue.

Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.

Your access to unlimited BenefitsPRO.com content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

Already have an account?


NOT FOR REPRINT

© 2023 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

 

BenefitsPRO Broker Expo 2024Event

The premier educational and networking event for employee benefits brokers and agents.

Get More Information
 

BenefitsPRO

Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.